Bipolar Disorder Treatment in York, PA: Diagnosis and Mood Stabilizer Care

The most effective bipolar disorder treatment is long-term mood stabilizer medication, often combined with an atypical antipsychotic and psychotherapy. Lithium remains the most evidence-based maintenance treatment — with the unique benefit of reducing suicide risk — per international guidelines including AAFP, APA, and CANMAT/ISBD.

For acute mania, first-line options include lithium, valproate, and atypical antipsychotics (quetiapine, aripiprazole, risperidone). For bipolar depression, first-line options include lurasidone, quetiapine, lamotrigine, and lithium. Treatment is tailored to the current phase and continued indefinitely because of the high relapse risk.

Yes. Psychiatric Mental Health Nurse Practitioners (PMHNP-BC) are licensed in Pennsylvania to diagnose bipolar disorder, prescribe mood stabilizers (lithium, valproate, lamotrigine, carbamazepine), atypical antipsychotics, and other psychotropic medications — working under Pennsylvania's collaborative-practice requirements for nurse practitioners — and provide psychotherapy. PMHNPs complete a master's or doctoral degree in psychiatric mental health nursing and pass a national board certification exam.

For most outpatient bipolar care, a PMHNP-BC provides comparable treatment to a psychiatrist — with typically shorter wait times. Both providers at Optimal Health York are board-certified PMHNPs. Severely complex or treatment-resistant bipolar cases may benefit from specialty consultation, which we facilitate when indicated.

Bipolar I requires at least one full manic episode — 7 or more days of elevated, expansive, or irritable mood with significant functional impairment, or any duration severe enough to require hospitalization. Depressive episodes typically also occur but aren't required for the diagnosis.

Bipolar II requires at least one hypomanic episode plus at least one major depressive episode — never a full manic episode. Hypomania is shorter (4+ days) and less severe than mania, often experienced as productive or pleasant by the person. Bipolar II is frequently misdiagnosed as unipolar depression because patients tend to seek help during depressive episodes, not hypomanic ones.

Timing depends on the phase being treated. For acute mania, atypical antipsychotics (quetiapine, olanzapine) often produce noticeable improvement within days to a week. Lithium and valproate typically require 1–3 weeks for full mood-stabilizing effect.

For bipolar depression, lurasidone and quetiapine work within 2–6 weeks. Lamotrigine requires slow titration over 6–8 weeks because of skin rash risk — the dose is increased gradually to therapeutic levels. Long-term maintenance benefits accumulate over months. We schedule close 30-minute follow-ups during titration to monitor response, side effects, and relevant blood levels (lithium, valproate, lamotrigine).

Yes — bipolar disorder evaluation and treatment is covered by all major insurance plans under federal mental health parity laws. We accept all major insurances. Call today to confirm your insurance. (717) 202-2285.

Most patients pay only their plan's specialist copay (typically $20–60). Self-pay rates are $249 for an initial evaluation and $99 for medication management follow-ups; psychotherapy begun within your visit is not billed separately. HSA, FSA, cash, credit card, and check accepted. Note: some bipolar medications — especially lithium — require periodic blood tests (lithium level, kidney function, thyroid), which are billed separately by your lab.

Yes. We provide full bipolar disorder treatment via telehealth across Pennsylvania, Maryland, and Virginia, including evaluations, medication management, and follow-up visits. Federal and state laws allow PMHNPs to prescribe mood stabilizers and atypical antipsychotics via telehealth.

You must be physically located in a state where your provider is licensed at the time of the visit. Abu Koroma sees patients in PA, MD, and VA (ages 12+); Zainab Koroma sees patients in PA and MD (ages 8+) including in-person at York. Note: patients on lithium or valproate need periodic blood draws at a local lab — we coordinate ordering and review results remotely.

Lithium has a strong safety record across nearly 70 years of clinical use when properly monitored. The most common side effects are mild tremor, increased thirst and urination, weight changes, and acne; less common but more serious are kidney and thyroid effects with long-term use. Lithium has a narrow therapeutic window, so blood levels and labs must be monitored regularly — we check serum lithium levels every 3–6 months once stable, and kidney and thyroid function every 6–12 months.

The trade-off is real: lithium is the only medication shown to significantly reduce suicide risk in bipolar disorder — an outcome no other mood stabilizer has matched. For many patients, this benefit is decisive. We discuss the risk-benefit balance carefully when deciding whether lithium fits your situation.

Yes — this is one of the most important reasons bipolar disorder needs accurate diagnosis. Antidepressants used alone (without a mood stabilizer) can trigger manic switching, mixed episodes, or rapid cycling in people with bipolar disorder. This is why bipolar depression is treated differently from unipolar depression.

If antidepressants are used in bipolar disorder, they're typically combined with a mood stabilizer or atypical antipsychotic, used at lower doses, and tapered off when the depressive episode resolves. SSRIs alone are generally avoided. This is also why bipolar II is so frequently missed — patients are treated with antidepressants for what looks like recurrent depression, sometimes for years, before the bipolar pattern is recognized.

Yes, with appropriate caveats. Zainab Koroma sees patients ages 8 and up at our York office and via telehealth in PA and MD. Abu Koroma sees ages 12 and up via telehealth in PA, MD, and VA. Pediatric bipolar disorder is complex to diagnose — symptoms often look different from adult bipolar (more irritability, less euphoria) and overlap with ADHD, ODD, and disruptive mood dysregulation disorder.

For diagnosed adolescent bipolar disorder, FDA-approved options include lithium, aripiprazole, risperidone, and quetiapine. We coordinate with parents, schools, and specialty pediatric psychiatry consultants when indicated. Children & adolescent care details.

New patient appointments at Optimal Health York are typically available within one week. Bipolar evaluations are 60-minute initial visits, allowing time for thorough mood history, family history, and ruling out other conditions; follow-ups are 30 minutes. Same-day and next-day telehealth appointments are often available depending on provider schedule. Call (717) 202-2285 to check current availability, or book online 24/7 through our HIPAA-compliant patient portal.

If you're in a manic or mixed episode with safety concerns, or having thoughts of suicide or self-harm, don't wait — call or text 988 (Suicide & Crisis Lifeline), call 911, or go to your nearest emergency room.